PHASE-II STUDY TO EVALUATE THE TOXICITY AND EFFICACY OF CONCURRENT CISPLATIN AND RADIATION-THERAPY IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX
Rg. Pearcey et al., PHASE-II STUDY TO EVALUATE THE TOXICITY AND EFFICACY OF CONCURRENT CISPLATIN AND RADIATION-THERAPY IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX, Gynecologic oncology, 58(1), 1995, pp. 34-41
Sixty patients presenting with poor prognosis squamous cell cancer of
the cervix have been studied in a phase II clinical trial, Patients we
re treated with radiotherapy and concurrent cisplatin chemotherapy eve
ry 10 days. Treatment was well tolerated with all patients completing
radiotherapy as prescribed. There was one case of grade 4 acute bowel
toxicity, Significant late morbidity was acceptable for this group of
patients being restricted to two cases (3.3%) of grade 4 toxicity to t
he bowel, Pelvic control rates of 78% have been observed. There have b
een no pelvic recurrences after 26 months, although recurrences beyond
the pelvis have occurred up to 4 years later, Actuarial 4-year surviv
al is encouraging at 60%. (C) 1995 Academic Press, Inc.